alexa Hyaluronan Reverses Imatinib Dependent-senescence In Chronic Myeloid Leukemia Cell Lines
ISSN: 2168-958X

Journal of Glycobiology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd Glycobiology World Congress
June 26-28, 2017 London, UK

Lompardia Silvina Laura, Díaz Mariángeles, Pibuel Matías, Papademetrio Daniela Laura, Mihalez Cintia Yamila, Levermann Martín, Álvarez Elida and Hajos Silvia Elvira
University of Buenos Aires, Argentina
Posters & Accepted Abstracts: J Glycobiol
DOI: 10.4172/2168-958X-C1-009
Abstract
Chronic myeloid leukemia (CML) is a myeloproliferative syndrome characterized by the presence of the Philadelphia chromosome which encodes a constitutively activated tyrosine kinase (BCR-ABL). The first line treatment for CML consists on BCR-ABL inhibitors such as Imatinib. Nevertheless, such treatment may lead to the selection of resistant cells. Hyaluronan (HA) is the main glycosaminoglycan of the extracellular matrix which is involved in tumor progression and multidrug resistance. We have previously demonstrated that HA induce cell proliferation in CML cells. However, the effect of HA on Imatinib therapy remains unknown. The aim of this work was to determine whether HA is able to reverse the anti-proliferative, pro-apoptotic and pro-senescent effect of Imatinib in human CML cell lines. For this purpose, K562 (ATCC) and Kv562 (multidrug resistant derived) were exposed to HA, Imatinib or a combination of both. Cell proliferation was evaluated by 3H-T uptake; apoptosis was determined by annexin-VPE- 7AAD kit, SubG1 peak and DNA fragmentation; senescence was evaluated by senescence-associated β-galactosidase activity (SA-β-gal) and senescence-associated heterochromatin foci (SAHF) presence. We showed that HA reversed the anti-proliferative effect of Imatinib without modifying Imatinib-dependent apoptosis in both cell lines. However, the combination of HA and Imatinib decreased SA-β-gal activity and SAHF presence when compared to Imatinib alone. Moreover, Imatinib treatment decreased pAkt/ Akt ratio in both cell lines and reduced the pERK/ERK ratio only in K562 cells, while the addition of HA reversed such effects. We conclude that HA reverses de anti-proliferative and pro-senescent effect of Imatinib without modifying apoptosis.
Biography

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords